Depression and Quality of Life in Chronic Heart Failure Patients and the Caregivers
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 51
- Locations
- 2
- Primary Endpoint
- Psychologic aspect
Study Overview
Brief Summary
Anxiety and depression are often present in patients with chronic heart failure (CHF). This study aimed to evaluate the influence of anxiety and depression on the physical function, disability, and quality of life (QOL) in CHF. This study examined the effects of 8-week home-based exercise on these parameters, and investigated the correlations between these outcome changes.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 20 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Clinical diagnosis of CHF for more than 6 months (NYHA Classes I-III)
- •Medically stable for at least 3 months
Exclusion Criteria
- •Malignancy
- •Psychiatric disease, primary neuromusculoskeletal or respiratory diseases that affected the assessment of functional or exercise capacity
- •Changes in medication occurred during the study period
Outcomes
Primary Outcomes
Psychologic aspect
Time Frame: 8 weeks
Anxiety and depression was measured by Hospital Anxiety and Depression Scale (HADS).
Functional capacity
Time Frame: 8 weeks
Functional capacity was assessed by six-minute walk test (6MWT).
Disability level
Time Frame: 8 weeks
Groningen Activity Restriction Scale (GARS)
Quality of life
Time Frame: 8 weeks
Minnesota Living with Heart Failure Questionnaire (MHFQ) was used to assess quality of life.
Secondary Outcomes
No secondary outcomes reported